Literature DB >> 32094052

Ethnic discordance in serum anti-Müllerian hormone in healthy women: a population study from China and Europe.

Scott M Nelson1, Sun Aijun2, Qui Ling2, Xu Tengda2, Xue Wei2, Deng Yan2, Wang Yanfang2, Tian Zenghui2, Chen Xinqi2, Abigail Fraser3, Gemma L Clayton3.   

Abstract

RESEARCH QUESTION: Chinese women are known to have an earlier age of natural menopause than their European counterparts, but whether they also have a lower functional ovarian reserve is unknown. This study was designed to assess whether there are ethnic differences in anti-Müllerian hormone (AMH) concentrations in women of reproductive age.
DESIGN: Women in China and Europe with regular menstrual cycles, not on hormonal contraception and with no medical history of note, were recruited to provide a day 2-5 early follicular phase sample. AMH concentration was determined using the Roche Elecsys assay. Decline in AMH was modelled with linear, quadratic and quadratic with interaction on age equations to assess the impact of ethnicity.
RESULTS: A total of 887 European and 461 Chinese women participated in the study. Despite the Chinese population being slightly younger (34.1 ± 8.4 years) than their European counterparts (34.8±8.9 years), their median AMH was lower, at 1.87 ng/ml (interquartile range [IQR] 0.28-3.64) compared with 2.11 ng/ml (IQR 0.73-3.96), with evidence of increasing discordance from age 25 years. In all regression models of the age-related decline in AMH, there was evidence of a difference between Chinese and European women. Although AMH was 28.1% (95% confidence interval [CI] 18.2-36.7%) lower in the Chinese population at age 30, this decline increased to 79.4% (95% CI 75.4- 82.9%) at age 45.
CONCLUSIONS: There were independent effects of age and ethnicity on serum AMH concentrations, with Chinese women having a substantially lower AMH in adult life than their European counterparts from age 25 onwards.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  AMH; Anti-Müllerian hormone; Ethnicity; Healthy population; Ovarian reserve

Mesh:

Substances:

Year:  2019        PMID: 32094052     DOI: 10.1016/j.rbmo.2019.11.013

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  10 in total

Review 1.  Anti-müllerian hormone as a predictor for live birth among women undergoing IVF/ICSI in different age groups: an update of systematic review and meta-analysis.

Authors:  Ni-Jie Li; Qing-Yun Yao; Xiao-Qiong Yuan; Yong Huang; Yu-Feng Li
Journal:  Arch Gynecol Obstet       Date:  2022-07-30       Impact factor: 2.493

2.  Improvement of anti-Müllerian hormone and oxidative stress through regular exercise in Chinese women with polycystic ovary syndrome.

Authors:  Xia Wu; Heng Wu; Wenjiang Sun; Chen Wang
Journal:  Hormones (Athens)       Date:  2020-07-28       Impact factor: 2.885

3.  Next Steps Toward AMH as a Robust Biomarker for Assessing Ovarian Aging in Individual Women.

Authors:  Bart C J M Fauser; Scott M Nelson
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

4.  High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment.

Authors:  Tie-Cheng Sun; Shan-Jie Zhou; Ling-Li Song; Jian-Hua Li; Xi Chen; Li Tian
Journal:  JBRA Assist Reprod       Date:  2021-04-27

5.  Performance characteristics of the Mindray chemiluminescence anti-Müllerian hormone assay.

Authors:  Jing-Jing Zhao; Chun-Min Kang; Peng Zhang; Lei Zheng
Journal:  J Clin Lab Anal       Date:  2021-03-04       Impact factor: 2.352

Review 6.  Ethnicity/Race and Age-Specific Variations of Serum AMH in Women-A Review.

Authors:  Alexander M Kotlyar; David B Seifer
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-09       Impact factor: 5.555

7.  Age-Specific Distribution of Serum Anti-Mullerian Hormone and Antral Follicle Count in Indian Infertile Women.

Authors:  Devika Gunasheela; Rajaam Murali; Lohith Chengappa Appaneravanda; Brigitte Gerstl; Arun Kumar; Nishanthini Sengeetha; Hita Nayak; P M Chandrikadevi
Journal:  J Hum Reprod Sci       Date:  2021-12-31

Review 8.  Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.

Authors:  Loes M E Moolhuijsen; Jenny A Visser
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

9.  Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients.

Authors:  Sandro C Esteves; Hakan Yarali; Lan N Vuong; José F Carvalho; İrem Y Özbek; Mehtap Polat; Ho L Le; Toan D Pham; Tuong M Ho
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

Review 10.  Impact of Obesity on Anti-Mullerian Hormone (AMH) Levels in Women of Reproductive Age.

Authors:  Alexis L Oldfield; Maryam Kazemi; Marla E Lujan
Journal:  J Clin Med       Date:  2021-07-20       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.